HRP20160783T1 - Medij za kultiviranje stanica za ekspresiju adamts proteina - Google Patents

Medij za kultiviranje stanica za ekspresiju adamts proteina Download PDF

Info

Publication number
HRP20160783T1
HRP20160783T1 HRP20160783TT HRP20160783T HRP20160783T1 HR P20160783 T1 HRP20160783 T1 HR P20160783T1 HR P20160783T T HRP20160783T T HR P20160783TT HR P20160783 T HRP20160783 T HR P20160783T HR P20160783 T1 HRP20160783 T1 HR P20160783T1
Authority
HR
Croatia
Prior art keywords
culture medium
protein
adamts
adamts13
culture
Prior art date
Application number
HRP20160783TT
Other languages
English (en)
Croatian (hr)
Inventor
Leopold Grillberger
Alexandra Spenger
Meinhard Hasslacher
Rana Grillberger
Manfred Reiter
Original Assignee
Baxalta GmbH
Baxalta Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxalta GmbH, Baxalta Incorporated filed Critical Baxalta GmbH
Publication of HRP20160783T1 publication Critical patent/HRP20160783T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489Metalloendopeptidases (3.4.24)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0681Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0684Cells of the urinary tract or kidneys
    • C12N5/0686Kidney cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24Metalloendopeptidases (3.4.24)
    • C12Y304/24087ADAMTS13 endopeptidase (3.4.24.87)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/12Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C12N2500/14Calcium; Ca chelators; Calcitonin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • C12N2500/22Zinc; Zn chelators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/38Vitamins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/90Serum-free medium, which may still contain naturally-sourced components
    • C12N2500/95Protein-free medium and culture conditions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/99Serum-free medium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
HRP20160783TT 2009-07-31 2010-07-30 Medij za kultiviranje stanica za ekspresiju adamts proteina HRP20160783T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23047709P 2009-07-31 2009-07-31
EP10740810.6A EP2459702B1 (en) 2009-07-31 2010-07-30 Cell culture medium for adamts protein expression
PCT/US2010/044020 WO2011014838A1 (en) 2009-07-31 2010-07-30 Cell culture medium for adamts protein expression

Publications (1)

Publication Number Publication Date
HRP20160783T1 true HRP20160783T1 (hr) 2016-08-12

Family

ID=42668009

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20160783TT HRP20160783T1 (hr) 2009-07-31 2010-07-30 Medij za kultiviranje stanica za ekspresiju adamts proteina

Country Status (21)

Country Link
US (7) US8313926B2 (OSRAM)
EP (1) EP2459702B1 (OSRAM)
JP (5) JP5451884B2 (OSRAM)
KR (5) KR101756354B1 (OSRAM)
CN (2) CN102549145B (OSRAM)
AU (1) AU2010278751B2 (OSRAM)
BR (2) BR112012002151B1 (OSRAM)
CA (1) CA2769361A1 (OSRAM)
CO (1) CO6501191A2 (OSRAM)
EA (1) EA023193B1 (OSRAM)
ES (1) ES2583258T3 (OSRAM)
HR (1) HRP20160783T1 (OSRAM)
HU (1) HUE029110T2 (OSRAM)
IN (1) IN2012DN00801A (OSRAM)
MX (2) MX2012001261A (OSRAM)
NZ (1) NZ597727A (OSRAM)
PL (1) PL2459702T3 (OSRAM)
PT (1) PT2459702T (OSRAM)
SG (1) SG178194A1 (OSRAM)
SI (1) SI2459702T1 (OSRAM)
WO (1) WO2011014838A1 (OSRAM)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101756354B1 (ko) * 2009-07-31 2017-07-26 백스터 인터내셔널 인코포레이티드 Adamts 단백질 발현을 위한 세포 배양 배지
EP3392271B8 (en) 2010-07-08 2021-06-16 Takeda Pharmaceutical Company Limited Method of producing recombinant adamts13 in cell culture
CN103827292B (zh) 2011-07-01 2018-01-26 安姆根有限公司 哺乳动物细胞培养
ES2633960T3 (es) 2012-10-15 2017-09-26 Bristol-Myers Squibb Company Procesos de cultivo de células de mamífero para la producción de proteínas
US9611455B2 (en) 2013-03-13 2017-04-04 Merck Sharp & Dohme Corp. Adapted lepidopteran insect cells for the production of recombinant proteins
US9217168B2 (en) 2013-03-14 2015-12-22 Momenta Pharmaceuticals, Inc. Methods of cell culture
AR095196A1 (es) * 2013-03-15 2015-09-30 Regeneron Pharma Medio de cultivo celular libre de suero
CA2926517C (en) * 2013-10-14 2021-03-23 Ares Trading S.A. New medium for high performance mammalian fed-batch cultures
IL294430B2 (en) 2014-06-04 2025-08-01 Amgen Inc Methods for harvesting mammalian cell cultures
KR101867134B1 (ko) * 2015-03-23 2018-06-12 한양대학교 산학협력단 포유류 세포를 이용하여 목적 물질을 고효율로 생산하기 위한 세포 배양 배지, 이를 이용한 세포 배양 방법 및 목적 물질의 생산 방법
US20180171323A1 (en) * 2015-05-22 2018-06-21 Dupont Nutrition Biosciences Aps Acetolactate decarboxylase
TW202440904A (zh) 2015-08-04 2024-10-16 美商再生元醫藥公司 補充牛磺酸之細胞培養基及用法(二)
JP2019527689A (ja) 2016-08-04 2019-10-03 バクスアルタ インコーポレイテッド 鎌状赤血球症における血管閉塞性クリーゼ、急性肺障害、および/または急性呼吸窮迫症候群を治療、改善および/または予防するためのadamts13の使用
MX2019004784A (es) * 2016-11-04 2019-08-12 Baxalta Inc Metodos de purificacion del virus adeno-asociado.
EP3649144A4 (en) * 2017-07-06 2021-07-21 Regeneron Pharmaceuticals, Inc. CELL CULTURE PROCESS TO PRODUCE GLYCOPROTEIN
CA3094076A1 (en) * 2018-03-16 2019-09-19 Genzyme Corporation Methods for improving cell viability in a production bioreactor
EP3807408A4 (en) * 2018-06-18 2022-03-30 Synthetic Biologics, Inc. METHODS OF MAKING ALKALINE PHOSPHATASE AGENTS
EP4037704A4 (en) 2019-10-04 2023-04-26 The Children's Medical Center Corporation ADAMTS13 TREATMENT TO IMPROVE TRANSPLANT SURVIVAL
US12297451B1 (en) 2019-10-25 2025-05-13 Regeneron Pharmaceuticals, Inc. Cell culture medium
TW202521150A (zh) 2019-12-06 2025-06-01 美商再生元醫藥公司 抗vegf蛋白組成物及其製備方法
JP2023521658A (ja) 2020-04-02 2023-05-25 武田薬品工業株式会社 Adamts13バリアント、組成物、及びその使用
JP2023525034A (ja) 2020-05-08 2023-06-14 リジェネロン・ファーマシューティカルズ・インコーポレイテッド Vegfトラップおよびミニトラップならびに眼障害およびがんの治療方法
EP4153215A1 (en) 2020-05-22 2023-03-29 Takeda Pharmaceutical Company Limited Adamts13 compositions and methods for treating and diagnosing complications of coronavirus disease
WO2021246557A1 (ko) * 2020-06-05 2021-12-09 주식회사 프로앱텍 특정한 갯수의 알부민이 연결된 요산산화효소-알부민 복합체 및 이의 제조 방법
CN111808822B (zh) * 2020-07-02 2024-01-12 北京百普赛斯生物科技股份有限公司 细胞培养用补料液及提高重组hek293细胞蛋白表达量的方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US5250421A (en) 1986-01-03 1993-10-05 Genetics Institute, Inc. Method for producing factor VIII:C-type proteins
CZ280901B6 (cs) 1988-10-06 1996-05-15 Hideaki Yamada Způsob kultivace bakterií
JPH0753104B2 (ja) * 1989-02-28 1995-06-07 秀明 山田 細菌の培養法
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
EP0791055B1 (en) 1994-11-10 2012-01-25 Baxter Healthcare S.A. Method for producing biologicals in protein-free culture
EP0811056B1 (en) 1995-02-23 2000-05-31 Quest International B.V. Peptides for tissue and cell culture media
US6013516A (en) 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
EP0953041A4 (en) 1996-08-30 2003-01-29 Life Technologies Inc SERUM-FREE CULTURAL MEDIUM FOR MAMMAL CELLS AND THEIR USE
IT1285158B1 (it) * 1996-09-17 1998-06-03 Angeletti P Ist Richerche Bio Polipeptidi solubili con l'attivita' di serino-proteasi di ns3 del virus dell'epatite c, e procedimento per la loro preparazione e il
UA59375C2 (uk) 1996-10-07 2003-09-15 Солюшіа Інк. Суміш для гідроксилювання, спосіб гідроксилювання ароматичних сполук та спосіб одержання фенолу
US6103529A (en) 1996-10-10 2000-08-15 Life Technologies, Inc. Animal cell culture media comprising peptides derived from rice
US5804420A (en) 1997-04-18 1998-09-08 Bayer Corporation Preparation of recombinant Factor VIII in a protein free medium
AT407255B (de) 1997-06-20 2001-02-26 Immuno Ag Rekombinanter zellklon mit erhöhter stabilität in serum- und proteinfreiem medium und verfahren zur gewinnung des stabilen zellklons
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
US5994136A (en) 1997-12-12 1999-11-30 Cell Genesys, Inc. Method and means for producing high titer, safe, recombinant lentivirus vectors
US6406909B1 (en) 1998-07-10 2002-06-18 Chugai Seiyaku Kabushiki Kaisha Serum-free medium for culturing animal cells
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
US6926894B2 (en) * 2000-11-22 2005-08-09 Baxter Aktiengesellschaft Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV
EP1576148B1 (en) 2002-12-23 2012-10-03 FUJIFILM Manufacturing Europe B.V. Process for coating cell-culture support
AU2005248299A1 (en) * 2004-04-16 2005-12-08 Wyeth ADAMTS-8 proteins and uses thereof
US20060094104A1 (en) 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
JP2007174948A (ja) * 2005-12-27 2007-07-12 Noritsu Koki Co Ltd 酵素水製造装置
JP4880997B2 (ja) * 2005-12-28 2012-02-22 アルフレッサファーマ株式会社 Adamts13の安定化方法
US20070212770A1 (en) 2006-01-04 2007-09-13 Baxter International Inc. Oligopeptide-free cell culture media
BRPI0622214A2 (pt) * 2006-12-22 2012-01-03 Springer Carrier Ltda unidade de condicionamento de ar e mÉtodo de misturar ar em uma unidade de condicionamento de ar
US20090067805A1 (en) 2007-09-10 2009-03-12 Victor Company Of Japan, Limited Recording and reproducing device
JP5727790B2 (ja) 2007-12-27 2015-06-03 バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated 細胞培養プロセス
KR101756354B1 (ko) * 2009-07-31 2017-07-26 백스터 인터내셔널 인코포레이티드 Adamts 단백질 발현을 위한 세포 배양 배지

Also Published As

Publication number Publication date
PT2459702T (pt) 2016-08-02
JP2014061005A (ja) 2014-04-10
JP5936232B2 (ja) 2016-06-22
CN104962539B (zh) 2019-09-17
US20110086413A1 (en) 2011-04-14
JP6511007B2 (ja) 2019-05-08
JP7083059B2 (ja) 2022-06-09
JP5451884B2 (ja) 2014-03-26
KR20150044981A (ko) 2015-04-27
US20190071660A1 (en) 2019-03-07
SI2459702T1 (sl) 2016-11-30
US10724024B2 (en) 2020-07-28
JP2021112210A (ja) 2021-08-05
JP6883071B2 (ja) 2021-06-09
JP6567707B2 (ja) 2019-08-28
CA2769361A1 (en) 2011-02-03
US9441216B2 (en) 2016-09-13
BR112012002151A2 (pt) 2020-03-03
KR101573972B1 (ko) 2015-12-02
HK1171790A1 (zh) 2013-04-05
US11254921B2 (en) 2022-02-22
KR101574056B1 (ko) 2015-12-02
IN2012DN00801A (OSRAM) 2015-06-26
JP2016144471A (ja) 2016-08-12
BR112012002151B1 (pt) 2021-07-06
AU2010278751B2 (en) 2014-05-15
KR20170081747A (ko) 2017-07-12
US20150329848A1 (en) 2015-11-19
JP2013500724A (ja) 2013-01-10
PL2459702T3 (pl) 2016-12-30
US20140329294A1 (en) 2014-11-06
AU2010278751A1 (en) 2012-02-09
EP2459702B1 (en) 2016-05-04
ES2583258T3 (es) 2016-09-20
NZ597727A (en) 2013-08-30
US10072254B2 (en) 2018-09-11
KR101756354B1 (ko) 2017-07-26
US9127265B2 (en) 2015-09-08
EP2459702A1 (en) 2012-06-06
BR122021005965B1 (pt) 2022-01-25
EA201270224A1 (ru) 2012-09-28
CO6501191A2 (es) 2012-08-15
US20130071906A1 (en) 2013-03-21
KR20170140411A (ko) 2017-12-20
EA023193B1 (ru) 2016-05-31
CN104962539A (zh) 2015-10-07
JP2018093881A (ja) 2018-06-21
SG178194A1 (en) 2012-03-29
KR101808496B1 (ko) 2017-12-12
US8313926B2 (en) 2012-11-20
CN102549145B (zh) 2015-05-20
KR101912552B1 (ko) 2018-10-26
MX344970B (es) 2017-01-12
CN102549145A (zh) 2012-07-04
JP2019201661A (ja) 2019-11-28
US8759026B2 (en) 2014-06-24
KR20120046301A (ko) 2012-05-09
US20170051270A1 (en) 2017-02-23
US20200308566A1 (en) 2020-10-01
MX2012001261A (es) 2012-05-22
KR20150138425A (ko) 2015-12-09
HUE029110T2 (en) 2017-02-28
WO2011014838A1 (en) 2011-02-03

Similar Documents

Publication Publication Date Title
HRP20160783T1 (hr) Medij za kultiviranje stanica za ekspresiju adamts proteina
JP2013500724A5 (OSRAM)
JP2019201661A5 (OSRAM)
NZ591292A (en) Improved cell composition and methods of making the same
NZ591244A (en) IDENTIFICATION AND USE OF BACTERIAL [2Fe-2S] DIHYDROXY-ACID DEHYDRATASES
DE69740002D1 (de) Tierzellen und verfahren für die replikation von influenza viren
BR122019022434B8 (pt) método para cultivar células de mamífero que secretam proteína heteróloga em um sobrenadante de cultura celular
DE60301031D1 (de) Verfahren zur Herstellung von L-Aminosäuren
ATE443757T1 (de) L-aminosäure produzierender mikroorganismus und verfahren zur l-aminosäureproduktion
DE602004014158D1 (de) Verfahren zur herstellung von l-lysin oder l-threonin unter verwendung von escherichia-bakterien mit abgeschwächter malatenzymaktivität
SI2590998T1 (en) Method for the preparation of a recombinant von Willerbrand factor of high molecular weight in cell culture
WO2009023525A3 (en) Methods of modulating mesenchymal stem cell differentiation
NZ587023A (en) Composition comprising protein and disperse fat
EA200900188A1 (ru) Улучшенный способ культивирования клеток
WO2006029198A3 (en) Culturing human embryonic stem cells
ATE414144T1 (de) Kulturen von e1-immortalisierten zellen und verfahren zu deren kultivierung zur erhöhung der produktausbeuten davon
Hölttä et al. Polyamine dependence of Chinese hamster ovary cells in serum-free culture is due to deficient arginase activity
WO2007115337A3 (en) Chondrocyte differentiation from human embryonic stem cells and their use in tissue engineering
DK1495112T3 (da) Cellekulturmedium
EP1687413B8 (en) Method for differentiating mesenchymal stem cell into neural cell and pharmaceutical composition containing the neural cell for neurodegenerative disease
TW200636068A (en) A method of culturing a cell and use of the same
NZ595833A (en) Method of producing a lipolytic enzyme
DE50312554D1 (de) Verfahren zur kultivierung von zellen zur produktion von substanzen
ATE517176T1 (de) Verfahren zur kultivierung von geschmackszellen aus säugern
CN103333856B (zh) 人脐带间充质干细胞培养基